Durham, NC, United States of America

Melinda S Fraiser


Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 532(Granted Patents)


Company Filing History:


Years Active: 1996-1999

Loading Chart...
6 patents (USPTO):

Title: Melinda S. Fraiser: Innovator in Mycobacterial Research

Introduction

Melinda S. Fraiser, an esteemed inventor based in Durham, NC, has made significant contributions to the field of microbiology through her innovative research. With a remarkable portfolio of six patents, Fraiser's work primarily focuses on processes for lysing mycobacteria, an essential area of study for advancements in medical diagnostics.

Latest Patents

Among her most notable patents is a process for lysing mycobacteria to liberate nucleic acids such as DNA and RNA. This groundbreaking procedure involves heating mycobacteria in an aqueous solution that contains chelating agents like EDTA or EGTA. The use of these agents plays a crucial role in inhibiting the degradation of the released nucleic acids. Notably, her inventions are capable of lysing important mycobacterial species, including Mycobacterium fortuitum and Mycobacterium tuberculosis. Following the lysis, the nucleic acids can be amplified and detected, with kits designed to facilitate these processes being disclosed in her patents.

Career Highlights

Melinda S. Fraiser holds a prominent position at Becton Dickinson and Company, a leader in medical technology. Her innovative spirit and scientific acumen have propelled her research to the forefront of mycobacterial studies, significantly impacting the landscape of clinical diagnostics and public health.

Collaborations

Throughout her career, Fraiser has worked alongside talented colleagues, including George T. Walker and Catherine A. Spargo. These collaborations have been instrumental in advancing her research, leading to the development of patents that contribute to enhanced diagnostic methodologies.

Conclusion

Melinda S. Fraiser's contributions to the field of microbiology exemplify the spirit of innovation and dedication to improving health outcomes. Her six patents underscore her expertise and commitment to advancing the understanding and management of mycobacterial diseases. As further developments arise from her research, the impact on medical science and diagnostics is sure to be profound.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…